Martingale Asset Management L P trimmed its position in shares of Masimo Corporation (NASDAQ:MASI) by 2.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,621 shares of the medical equipment provider’s stock after selling 1,500 shares during the period. Martingale Asset Management L P owned approximately 0.14% of Masimo Corporation worth $6,622,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. BlackRock Inc. increased its stake in Masimo Corporation by 4,676.3% during the first quarter. BlackRock Inc. now owns 7,364,235 shares of the medical equipment provider’s stock valued at $686,789,000 after acquiring an additional 7,210,051 shares during the period. Vanguard Group Inc. increased its stake in Masimo Corporation by 5.9% during the first quarter. Vanguard Group Inc. now owns 4,617,633 shares of the medical equipment provider’s stock valued at $430,641,000 after acquiring an additional 258,719 shares during the period. Acadian Asset Management LLC increased its stake in Masimo Corporation by 28.0% during the second quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock valued at $163,356,000 after acquiring an additional 392,410 shares during the period. State Street Corp increased its stake in Masimo Corporation by 42.8% during the first quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock valued at $130,704,000 after acquiring an additional 419,767 shares during the period. Finally, Robeco Institutional Asset Management B.V. increased its stake in Masimo Corporation by 27.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after acquiring an additional 233,412 shares during the period. Hedge funds and other institutional investors own 83.26% of the company’s stock.
Shares of Masimo Corporation (MASI) opened at 86.86 on Tuesday. The stock has a 50 day moving average price of $87.68 and a 200 day moving average price of $91.22. The company has a market capitalization of $4.51 billion, a price-to-earnings ratio of 14.24 and a beta of 0.84. Masimo Corporation has a 1-year low of $53.78 and a 1-year high of $104.71.
Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. During the same period in the previous year, the business earned $0.57 earnings per share. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. Analysts forecast that Masimo Corporation will post $2.80 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “Martingale Asset Management L P Lowers Position in Masimo Corporation (MASI)” was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://sportsperspectives.com/2017/09/12/martingale-asset-management-l-p-lowers-position-in-masimo-corporation-masi.html.
In other news, COO Anand Sampath sold 40,000 shares of Masimo Corporation stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total value of $3,680,000.00. Following the completion of the sale, the chief operating officer now directly owns 20,000 shares in the company, valued at $1,840,000. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Sanford Fitch sold 6,000 shares of Masimo Corporation stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total transaction of $551,340.00. Following the completion of the sale, the director now owns 89,249 shares of the company’s stock, valued at $8,201,090.61. The disclosure for this sale can be found here. Over the last quarter, insiders sold 126,000 shares of company stock valued at $11,732,930. 16.60% of the stock is owned by company insiders.
Several equities analysts recently issued reports on MASI shares. Wedbush restated an “outperform” rating and set a $112.00 price target on shares of Masimo Corporation in a research note on Monday, May 22nd. Zacks Investment Research lowered Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. BidaskClub lowered Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Stifel Nicolaus initiated coverage on Masimo Corporation in a research note on Monday, July 10th. They issued a “buy” rating and a $105.00 price objective on the stock. Finally, Roth Capital upped their price objective on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the stock. Masimo Corporation currently has an average rating of “Hold” and a consensus price target of $95.00.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.